Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
- Posted on April 16, 2025
- Drugs (Pharmaceuticals)
- By The New York Times
- 3 Views
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. continue reading...
